NCT03586427: A reported trial by Syndeio Biosciences, Inc
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03586427 |
|---|---|
| Title | A Double-Blind, Placebo-Controlled, Fixed-Dose Study of AGN-241751 in Adult Participants With Major Depressive Disorder |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 13, 2018 |
| Completion date | July 22, 2019 |
| Required reporting date | July 22, 2022, midnight |
| Actual reporting date | July 9, 2022 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |